Midjourney’s dolphin tank scanner draws medical skepticism

Midjourney's whole-body ultrasound scanner pioneers a novel Ultrasonic CT technology by submerging patients in a water tank ringed with hundreds of thousands of ultrasonic emitters and receivers. This design, co-developed with Butterfly Network using 40 Ultrasound-on-Chip modules, enables the device to emit and capture soundwaves from every angle, reconstructing detailed 3D images of muscle, fat, bone, and organs with millimeter precision. The company likens this process to being surrounded by half a million tiny dolphins using echolocation, creating a rich, MRI-like visualization without radiation or magnetic fields.

The scanner achieves a remarkable speed advantage, completing full-body imaging in roughly 20 to 60 seconds—up to 100 times faster than traditional MRI scans that often take over an hour. This rapid throughput is powered by processing an enormous data volume, approximately 800 terabytes per scan, allowing for quick, high-definition 3D reconstructions. By eliminating radiation and magnets, Midjourney positions its technology as a safer and more patient-friendly alternative, potentially enabling frequent, longitudinal imaging at a fraction of MRI’s cost.

Midjourney’s approach leverages Butterfly Networks’ transistor-based ultrasound sensor IP to build a scalable, cost-effective imaging platform that could disrupt the traditional MRI market. By stacking these sensors into a ring and integrating them into an elaborate water bath system, the company aims to reduce scan costs to as low as one-tenth or even one-hundredth of MRI expenses. This hardware innovation supports Midjourney’s ambitious plan to deploy tens of thousands of scanners, starting with a commercial launch in San Francisco by 2028 and targeting up to a billion scans per month by 2031.

Midjourney's rapid, radiation-free whole-body ultrasound scanner promises to usher in a new era of patient empowerment by enabling on-demand health monitoring without traditional doctor orders, as seen in their planned spa deployment in San Francisco's Union Square. However, clinicians caution that ultrasound's fundamental physical limitations—such as poor penetration through bone or air and limited contrast resolution—may restrict its diagnostic accuracy, challenging the assumption that more frequent scans inherently improve health outcomes. Decades of oncology research further complicate this narrative, revealing that early detection does not uniformly translate to better prognoses, since many cancers remain untreatable regardless of detection timing.

The clinical promise of AI-driven analysis integrated with Midjourney's scanner is met with cautious optimism, as experts debate whether artificial intelligence can effectively mitigate the high risk of overdiagnosis and false positives inherent in whole-body screening. While AI offers potential to enhance diagnostic precision, clinicians emphasize that indiscriminate scanning of generally healthy individuals often leads to incidental findings that trigger unnecessary biopsies, anxiety, and increased healthcare costs without clear evidence of improved survival rates. This tension underscores the need for robust validation to avoid a 'snake oil' scenario where technology outpaces evidence-based medicine.

Midjourney's approach reflects a broader shift toward greater patient autonomy in health data access, challenging traditional medical gatekeeping by offering whole-body imaging directly to consumers. Yet this empowerment raises ethical and liability concerns, as increased screening may incentivize downstream interventions that burden both patients and healthcare systems. Clinicians warn that balancing innovation with evidence-based outcomes is critical to prevent a return to an era of unproven health remedies sold at high cost, highlighting the complex interplay between patient choice, medical incentives, and the potential harms of overdiagnosis.

Midjourney has set an extraordinarily ambitious target to deploy 50,000 whole-body ultrasound scanners globally by 2031, aiming to perform a staggering one billion scans per month. This vision includes opening spa-based scanning centers, starting with a flagship location in San Francisco’s Union Square by the end of 2027, where 10 scanners will be integrated alongside wellness amenities like hot tubs and saunas to attract users seeking convenient, on-demand imaging. By situating scanners in spa environments, Midjourney hopes to leverage the rapid, roughly one-minute scan time and significantly lower costs—projected at $100 to $200 per scan compared to traditional $2,000 to $5,000 MRIs—to disrupt the existing imaging market dominated by providers such as Prenuvo.

Despite the compelling market strategy, scaling this medical AI technology to meet throughput goals presents daunting financial and infrastructural challenges. Achieving a billion scans monthly would require each scanner to perform a scan every 130 seconds without pause, a pace that experts deem unrealistic given current scanning durations. Furthermore, Midjourney’s plan to operate approximately 5,000 spa centers worldwide—each housing around 10 scanners—entails massive investments, including the need for $10 million server farms per spa, pushing total infrastructure costs into the hundreds of billions. Skeptics question the feasibility of making such technology affordable and accessible to a billion people, highlighting the enormous data processing and equipment demands that could stymie widespread deployment.

Midjourney’s pivot from AI image generation to developing proprietary hardware like the whole-body ultrasound scanner signals a strategic effort to establish a competitive moat through specialized medical devices. By building a global fleet of scanners and embedding them within spa-based centers, the company aims not only to disrupt imaging costs and convenience but also to generate proprietary data streams that could fuel future AI advancements. This hardware-centric approach reflects a broader ambition to create a new vector for disruption in medical diagnostics, positioning Midjourney as a formidable player in both technology and healthcare infrastructure.

Medical experts express deep skepticism about the diagnostic validity of Midjourney's whole-body ultrasound scanner, emphasizing that fundamental physical limitations of ultrasound—such as its inability to penetrate bone or air—cannot be overcome merely by increasing scan frequency. As Hopkins Medicine assistant professor Francis Deng notes, many body parts remain inaccessible, and claims of 'subatomic resolution' lack substantiation, with no patient imaging evidence provided. Critics label the technology as premature 'vaporware,' pointing out that it is based on a 2026 paper without demonstrated cutting-edge imaging capabilities, underscoring the gap between marketing hype and clinical reality.

The lack of FDA clearance and regulatory uncertainty loom large as significant hurdles for Midjourney's device, raising questions about safety, efficacy, and the legitimacy of unproven claims. Experts highlight that unlike established MRI screening tools, which benefit from decades of rigorous validation and FDA approval, Midjourney’s scanner operates in a regulatory 'gray area' without clear oversight or reimbursement pathways. This absence of formal approval not only fuels skepticism but also limits the technology’s scalability, confining it to a small cash-pay market and increasing the risk of misleading patients with unsupported diagnostic assertions.

Concerns about overdiagnosis and patient harm permeate expert critiques, as indiscriminate whole-body scanning risks generating false positives that lead to unnecessary biopsies, anxiety, and costly follow-up procedures. Drawing parallels to the known pitfalls of full-body MRI screening, clinicians warn that even a technology with 95% accuracy can produce overwhelming false alarms when applied broadly, subjecting healthy individuals to the stress of potentially harmful interventions. The rapid scale-up plans to scan millions monthly without robust clinical data exacerbate fears that the device could contribute to a cascade of medical overuse rather than meaningful health benefits.

Beyond technical and regulatory issues, practical and ethical challenges arise from Midjourney’s approach, including patient discomfort from submersion during scanning and the difficulty of interpreting incidental findings outside traditional clinical oversight. Experts like NYU’s Laura Heacock question the feasibility of requiring patients to lie submerged in water, while others emphasize the need for clinicians to contextualize ambiguous results to mitigate anxiety. Moreover, concerns about autonomy, liability, and financial incentives highlight the complex downstream consequences of deploying unvalidated whole-body imaging technologies directly to consumers without clear guidelines or safeguards.